The Department of Veterans Affairs (VA) has awarded Biodesix, Inc., a for-profit medical laboratory and diagnostic testing company based in Boulder, Colorado, a $20.3 million multiple-award Federal Supply Schedule contract for medical laboratory testing and analysis services. This contract enables VA medical centers to issue task orders for Biodesix's specialized lung testing capabilities, including Nodify lung blood testing, STX lung cancer screening, and other diagnostic testing options. Biodesix has also been awarded a $2.25 million Blanket Purchase Agreement (BPA) for STX Nodify lung cancer screening services, as well as two single-award Indefinite Delivery Contracts totaling $700,000 and $216,735 for lung testing services across multiple VA regions. These Indefinite Delivery Vehicles (IDVs) have contract periods extending through September 2029, allowing the VA to continue accessing Biodesix's innovative diagnostic technologies to support healthcare programs for veterans.
The VA has awarded Biodesix a $61,043.55 firm fixed price delivery order contract through the Veterans Integrated Service Network 10 (VISN 10) for lung testing services with a one-year period of performance. This delivery order was issued against an unspecified government-wide acquisition contract vehicle or blanket purchase agreement to procure lung testing in support of healthcare programs for veterans served by the VA network. Biodesix has consistently provided lung blood testing services to various VA medical centers and regional networks, demonstrating its strategic approach to supporting veteran healthcare through its specialized diagnostic expertise.
Generated 2/13/25, 9:06 AM